title: Use of the stationary phase inducible promoters, spv and dps, to drive heterologous antigen expression in Salmonella vaccine strains.
abstract: We have investigated the ability of the growth phase regulated promoters dps and spv, to drive expression of heterologous antigens in Salmonella vaccine strains. Reporter plasmids were constructed which directed beta-galactosidase expression from dps (pDpslacZ) or spv (pSpvlacZ) and these were introduced independently into the Salmonella typhimurium vaccine strain SL3261 (aroA(-)). beta-galactosidase expression was induced 20-fold and 100-fold when broth cultures of SL3261 (pDpslacZ) or SL3261 (pSpvlacZ) respectively, entered the stationary phase of growth. Within macrophages, beta-galactosidase expression was induced 3.5-fold with SL3261 (pDpslacZ) and 7-fold with SL3261 (pSpvlacZ). The spv and dps promoters were used to drive independent expression of the C fragment domain of tetanus toxin (TetC) from plasmids harboured in S. typhimurium SL3261. Levels of anti-TetC antibodies were significantly higher in the sera of BALB/c mice perorally inoculated with SL3261 (pSpvtetC) or SL3261 (pDpstetC) compared to unvaccinated controls. This suggests that these promoter systems may be used to drive foreign antigen expression in live oral Salmonella vaccines.
authors.affiliation: Department of Microbiology, Moyne Institute of Preventive Medicine, Trinity College, Dublin, Ireland. dmrshall@tcd.ie
authors.forename: D G
authors.initials: DG
authors.lastname: Marshall
authors.forename: A
authors.initials: A
authors.lastname: Haque
authors.forename: R
authors.initials: R
authors.lastname: Fowler
authors.forename: G
authors.initials: G
authors.lastname: Del Guidice
authors.forename: C J
authors.initials: CJ
authors.lastname: Dorman
authors.forename: G
authors.initials: G
authors.lastname: Dougan
authors.forename: F
authors.initials: F
authors.lastname: Bowe
mesh_terms: D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology*; D001428:Bacterial Vaccines; D002455:Cell Division; D002478:Cells, Cultured; D004268:DNA-Binding Proteins / Q000235:genetics / Q000276:immunology*; D015964:Gene Expression Regulation, Bacterial; D008264:Macrophages / Q000378:metabolism; D051379:Mice; D011401:Promoter Regions, Genetic; D012097:Repressor Proteins / Q000096:biosynthesis / Q000235:genetics / Q000276:immunology; D012486:Salmonella typhimurium / Q000276:immunology*; D014162:Transfection; D014614:Vaccines, Synthetic / Q000235:genetics / Q000276:immunology
chemical_list: D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001428:Bacterial Vaccines; D004268:DNA-Binding Proteins; C083911:DPS protein, Bacteria; D012097:Repressor Proteins; C107173:TetC protein, Bacteria; D014614:Vaccines, Synthetic